bibliographicCitation |
YAMAMOTO A, WATANABE H, SUEKI H, NAKANISHI T, YASUHARA H, IIJIMA M. Vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK 222584 inhibits both the induction and elicitation phases of contact hypersensitivity. The Journal of Dermatology. 2007 Jun 19;34(7):419–29. doi: 10.1111/j.1346-8138.2007.00304.x. |